000 | 01952 a2200553 4500 | ||
---|---|---|---|
005 | 20250516062101.0 | ||
264 | 0 | _c20120702 | |
008 | 201207s 0 0 eng d | ||
022 | _a1941-7632 | ||
024 | 7 |
_a10.1161/CIRCINTERVENTIONS.111.963884 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPalmerini, Tullio | |
245 | 0 | 0 |
_aPredictors and implications of stent thrombosis in non-ST-segment elevation acute coronary syndromes: the ACUITY Trial. _h[electronic resource] |
260 |
_bCirculation. Cardiovascular interventions _cDec 2011 |
||
300 |
_a577-84 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAcute Coronary Syndrome _xpathology |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAngioplasty, Balloon, Coronary |
650 | 0 | 4 | _aComorbidity |
650 | 0 | 4 |
_aCoronary Thrombosis _xepidemiology |
650 | 0 | 4 |
_aCoronary Vessels _xpathology |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xepidemiology |
650 | 0 | 4 |
_aDrug-Eluting Stents _xadverse effects |
650 | 0 | 4 | _aElectrocardiography |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFibrinolytic Agents _xtherapeutic use |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMetals |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 | _aPrevalence |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aStents _xadverse effects |
700 | 1 | _aDangas, George | |
700 | 1 | _aMehran, Roxana | |
700 | 1 | _aCaixeta, Adriano | |
700 | 1 | _aGénéreux, Philippe | |
700 | 1 | _aFahy, Martin P | |
700 | 1 | _aXu, Ke | |
700 | 1 | _aCristea, Ecaterina | |
700 | 1 | _aLansky, Alexandra J | |
700 | 1 | _aStone, Gregg W | |
773 | 0 |
_tCirculation. Cardiovascular interventions _gvol. 4 _gno. 6 _gp. 577-84 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1161/CIRCINTERVENTIONS.111.963884 _zAvailable from publisher's website |
999 |
_c21259734 _d21259734 |